ReNeuron Group plc

Company Profile

Company website
Pharmaceuticals and Biotechnology (Biotechnology)
ReNeuron Group plc (AIM: RENE) is a global leader in cell-based therapeutics, harnessing its unique stem cell technologies to develop 'off the shelf' stem cell treatments, without the need for immunosuppressive drugs.

Investor Access

02 Dec
Event information

Management announced its unaudited interim results for the six months ended 30 September 2022 on Friday 2nd December 2022.

Friday 2nd December 2022
Financial Calendar
 Event  Date
Year End 31 March
Half  Year End 30 September
Preliminary Results* July
Interim Results* December
AGM* September

* Months based on previous announcements of this kind